Delta-Like Ligand 3 (DLL3) is a promising target in small cell lung cancer | 1 |
DLL3 is highly expressed in neuroendocrine subtypes of SCLC | 2 |
DLL3-targeting CAR T showed robust in-vitro cytotoxicity against SCLC | 3 |
Made with FlippingBook interactive PDF creator